Latest Insider Transactions at Vaccitech PLC (VACC)
This section provides a real-time view of insider transactions for Vaccitech PLC (VACC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Vaccitech plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Vaccitech plc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 26
2023
|
Joseph Scheeren Director |
BUY
Open market or private purchase
|
Direct |
10,000
+30.3%
|
$20,000
$2.44 P/Share
|
|
May 25
2023
|
Robin Wright Director |
BUY
Open market or private purchase
|
Direct |
13,750
+22.18%
|
$27,500
$2.66 P/Share
|
|
Mar 27
2023
|
William Enright Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
15,000
-2.02%
|
$30,000
$2.42 P/Share
|
|
Sep 30
2022
|
M&G Investment Management LTD > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
4,108,752
+44.15%
|
-
|
|
Sep 30
2022
|
M&G Alternatives Investment Management LTD > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
4,108,752
-100.0%
|
-
|
|
Aug 25
2022
|
Graham Griffiths Chief Business Officer |
SELL
Open market or private sale
|
Direct |
10,000
-8.76%
|
$70,000
$7.39 P/Share
|
|
Aug 25
2022
|
Christopher Ellis Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
39,176
-67.91%
|
$235,056
$6.38 P/Share
|
|
Aug 25
2022
|
Christopher Ellis Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
39,176
+49.95%
|
-
|
|
Aug 24
2022
|
Christopher Ellis Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
450
-85.71%
|
$1,800
$4.78 P/Share
|
|
Aug 24
2022
|
Christopher Ellis Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
450
+46.15%
|
-
|
|
Aug 18
2022
|
Christopher Ellis Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,175
-96.67%
|
$8,700
$4.84 P/Share
|
|
Aug 18
2022
|
Christopher Ellis Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,175
+49.15%
|
-
|
|
Aug 17
2022
|
Graham Griffiths Chief Business Officer |
SELL
Open market or private sale
|
Direct |
500
-0.44%
|
$2,000
$4.76 P/Share
|
|
Aug 17
2022
|
Christopher Ellis Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
649
-89.64%
|
$2,596
$4.77 P/Share
|
|
Aug 17
2022
|
Christopher Ellis Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
649
+47.27%
|
-
|
|
Aug 16
2022
|
Graham Griffiths Chief Business Officer |
SELL
Open market or private sale
|
Direct |
1,220
-1.05%
|
$4,880
$4.82 P/Share
|
|
Aug 16
2022
|
Christopher Ellis Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,200
-96.7%
|
$8,800
$4.78 P/Share
|
|
Aug 16
2022
|
Christopher Ellis Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,200
+49.16%
|
-
|
|
Aug 15
2022
|
Graham Griffiths Chief Business Officer |
SELL
Open market or private sale
|
Direct |
2,400
-2.03%
|
$9,600
$4.75 P/Share
|
|
Aug 15
2022
|
Christopher Ellis Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,350
-98.62%
|
$21,400
$4.76 P/Share
|
|
Aug 15
2022
|
Christopher Ellis Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,350
+49.65%
|
-
|
|
Aug 12
2022
|
Graham Griffiths Chief Business Officer |
SELL
Open market or private sale
|
Direct |
5,000
-4.05%
|
$20,000
$4.5 P/Share
|
|
Jun 28
2022
|
Christopher Ellis Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5
-6.25%
|
$30
$6.0 P/Share
|
|
Jun 28
2022
|
Christopher Ellis Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5
+5.88%
|
-
|
|
Jun 24
2022
|
Graham Griffiths Chief Business Officer |
BUY
Small Acquisition
|
Direct |
100
+0.08%
|
$500
$5.87 P/Share
|
|
Jun 23
2022
|
Graham Griffiths Chief Business Officer |
SELL
Open market or private sale
|
Direct |
8
-0.01%
|
$40
$5.28 P/Share
|
|
Jun 23
2022
|
Graham Griffiths Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,338
+1.98%
|
-
|
|
Apr 01
2022
|
Joseph Scheeren Director |
BUY
Open market or private purchase
|
Direct |
10,000
+43.48%
|
$50,000
$5.09 P/Share
|
|
Mar 31
2022
|
Alex Hammacher Director |
BUY
Open market or private purchase
|
Direct |
2,000
+40.0%
|
$10,000
$5.14 P/Share
|
|
Dec 31
2021
|
Alex Hammacher Director |
BUY
Open market or private purchase
|
Direct |
1,000
+50.0%
|
$10,000
$10.86 P/Share
|
|
Dec 22
2021
|
Robin Wright Director |
BUY
Open market or private purchase
|
Direct |
10,000
+22.47%
|
$90,000
$9.97 P/Share
|
|
May 04
2021
|
Oxford Sciences Innovation PLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
600,000
+6.38%
|
$10,200,000
$17.0 P/Share
|
|
May 04
2021
|
Oxford Sciences Innovation PLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
8,197,770
+29.18%
|
-
|
|
May 04
2021
|
Anne M. Phillips Director |
BUY
Open market or private purchase
|
Direct |
3,000
+50.0%
|
$51,000
$17.0 P/Share
|
|
May 04
2021
|
Joseph Scheeren Director |
BUY
Open market or private purchase
|
Direct |
3,000
+50.0%
|
$51,000
$17.0 P/Share
|
|
May 04
2021
|
Christopher Ellis Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
75
+50.0%
|
$1,275
$17.0 P/Share
|
|
May 04
2021
|
Robin Wright Director |
BUY
Open market or private purchase
|
Direct |
14,000
+36.36%
|
$238,000
$17.0 P/Share
|
|
May 04
2021
|
Graham Griffiths Chief Business Officer |
BUY
Open market or private purchase
|
Direct |
100
+50.0%
|
$1,700
$17.0 P/Share
|
|
May 04
2021
|
Karen A Dawes Director |
BUY
Open market or private purchase
|
Direct |
1,700
+50.0%
|
$28,900
$17.0 P/Share
|
|
Apr 30
2021
|
M&G Investment Management LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
125,000
+10.3%
|
$1,750,000
$14.4 P/Share
|
|
Apr 29
2021
|
William Enright Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
455,775
+27.54%
|
-
|